Marco Maria Brughera

Insider activity · 24 months0 buys1 saleCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 1 saleOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (1 ops.)

€139k

Latest filing published 16 Sept 2026 for Fennec Pharmaceuticals INC., €28k. Read the official filing

Filing timeline

BuySale

Marco Maria Brughera

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Marco Maria Brughera: trading record in brief

Marco Maria Brughera appears in our data through filings on Fennec Pharmaceuticals Inc. shares, published by SEC (Form 4). Activity is concentrated on a single trading day, 15 September 2026, with 2 filings.

Sales make up the whole of the open-market record (1 sale, €139k). Besides market trades, the filings include 1 option exercise.

The newest entry dates from 16 September 2026: an open-market sale of €139k, in Fennec Pharmaceuticals Inc. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.